Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

 Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Shots:

  • Roche has launched Elecsys Anti-SARS-CoV-2 S Ab for markets accepting the CE Mark. The company has filed for US FDA’s EUA
  • The test can quantitatively measure the level of Abs against SARS-CoV-2 in patients who have been exposed to the virus and can aid in characterizing a vaccine-induced immune response
  • Using the Elecsys Anti-SARS-COV-2 S Ab test together with the Elecsys Anti-SARS-CoV-2 test-launched in May’2020, can aid effectively in determining the percentage of a population who already have Abs against SARS-COV-2

Click here ­to­ read full press release/ article | Ref: Roche | Image: NS HealthCare

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post